Bilateral subthalamotomy in Parkinson's disease: Initial and long-term response

Brain

Volumn 128, Issue 3, 2005, Pages 570-583

  Alvarez, L ^a   Macias, R ^a   Lopez, G ^a   Alvarez, E ^a   Pavon, N ^a   Rodriguez Oroz, M C ^b   Juncos, J L ^d   Maragoto, C ^a   Guridi, J ^b   Litvan, I ^e   Tolosa, E S ^c   Koller, W ^f   Vitek, J ^d   DeLong, M R ^d   Obeso, Jose A ^b  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c Universitari Vall d'Hebron   (Spain)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e University of Louisville School of Medicine   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Motor complications; Parkinson's disease; Subthalamic nucleus; Subthalamotomy; Surgery

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; BENSERAZIDE; BROMOCRIPTINE; CARBIDOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PHENYTOIN; SULPIRIDE; TETRABENAZINE; TRIHEXYPHENIDYL; ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; ATAXIA; BILATERAL SUBTHALAMOTOMY; BRADYKINESIA; CHOREA; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DISEASE DURATION; DRUG WITHDRAWAL; DYSARTHRIA; DYSKINESIA; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HUMAN; MALE; MOTOR PERFORMANCE; MUSCLE RIGIDITY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; PARKINSON DISEASE; PILOT STUDY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RATING SCALE; SPEECH; SUBTHALAMIC NUCLEUS; SURGICAL INFECTION; SURGICAL TECHNIQUE; THALAMOTOMY; TREMOR; VIDEORECORDING; WOUND DRAINAGE; DRUG ADMINISTRATION; EVALUATION; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; RADIOSURGERY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTIPARKINSON AGENTS; COGNITION; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 20144375351     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh397     Document Type: Article

References (90)

1. Alterman RL, Reiter GT, Shils J, Skolnick B, Arle JE, Lesutis M, et al. Targeting for thalamic deep brain stimulator implantation without computer guidance: assessment of targeting accuracy. Stereotact Funct Neurosurg 1999; 72: 150-3.
2. Alvarez L, Macias R, Lopez G, Alvarez E, Maragoto C, Teijeiro J, et al. Bilateral subthalamotomy in Parkinson's disease. Mov Disord 2000; 15 (Suppl 3): 65.
3. Alvarez L, Macias R, Guridi J, Lopez G, Alvarez E, Maragoto CT, et al. Dorsal subthalamotomy for Parkinson's disease. Mov Disord. 2001; 16: 72-8.
4. Baron MS, Vitek JL, Bakay RA, Green J, Kaneoke Y, Hashimoto T, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40: 355-66.
5. Baron MS, Sidibe M, DeLong MR, Smith Y. Course of motor and associative pallidothalamic projections in monkeys. J Comp Neurol 2001; 429: 490-501.
6. Baunez C, Amalric M, Robbins TW. Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. J Neurosci 2002; 22: 562-8.
7. Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 1994; 62: 76-84.
8. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249: 1436-8.
9. Bevan MD, Magill PJ, Terman D, Bolam JP, Wilson CJ. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 2002; 25: 525-31.
10. Brotchie JM, Mitchell IJ, Sambrook MA, Crossman AR. Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov Disord 1991; 6: 133-8.
11. Bronstein JM, DeSalles A, DeLong MR. Stereotactic pallidotomy in the treatment of Parkinson disease: an expert opinion. Arch Neurol 1999; 56: 1064-9.
12. Carbon M, Eidelberg D. Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography. Curr Opin Neurobiol 2002; 15: 451-5.
13. Chen CC, Lee ST, Wu T, Chen CJ, Huang CC, Lu CS. Hemiballism after subthalamotomy in patients with Parkinson's disease: report of 2 cases. Mov Disord 2002; 17: 1367-71.
14. Crossman AR. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience 1987; 21: 1-40.
15. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-14.
16. Delfs JM, Ciaramitaro VM, Parry TJ, Chesselet MF. Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. J Neurosci 1995; 15: 6562-75.
17. DeLong MR. Primate models of movement disorders of basal ganglia origen. Trends Neurosci 1990; 13: 281-5.
18. DeLong MR, Georgopoulus AP. Motor functions of the basal ganglia. In: Handbook of physiology. The nervous system II. American Physiological Society; 1981. Vermon B, Brooks (eds), Oxford University Press. p. 1017-61.
19. Dierssen G, Gioino L. Correlación anatómica del hemibalismo. Rev Clin Esp 1961; 82: 283-305.
20. Dierssen G, Bergmann L, Gioino L, Cooper IS. Hemiballism following surgery for Parkinson's disease. Arch Neurol 1961; 5: 627-37.
21. Doshi P, Bhatt M. Hemiballism during subthalamic nucleus lesioning. Mov Disord 2002; 17: 848-9.
22. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621-6.
23. Eskandar EN, Flaherty A, Cosgrove GR, Shinobu LA, Barker FG. Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample. J Neurosurg 2003; 99: 863-71.
24. Favre J, Burchiel KJ, Taha JM, Hammerstad J. Outcome of unilateral and bilateral pallidotomy for Parkinson's disease: patient assessment. Neurosurgery 2000; 46: 344-355.
25. Fine J, Duff J, Chen R, Chir B, Hutchison W, Lozano AM, et al. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med 2000; 342: 1708-14.
26. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
27. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-9.
28. Gill SS, Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet 1997; 350: 1224.
29. Goetz CG, Stebbins GT, Shale HM, Lang AE, Chernik DA, et al. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord 1994; 9: 390-4.
30. Goetz CG, Leurgans S, Raman R, Parkinson Study Group. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord 2002; 17: 283-8.
31. Guridi J, Obeso JA. The role of the subthalamic nucleus in the origin of hemiballism and Parkinson's disease. Adv Neurol 1997; 74: 235-47.
32. Guridi J, Obeso JA. The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. Brain 2001; 124: 5-19.
33. Guridi J, Luquin MR, Herrero MT, Obeso JA. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov Disord 1993; 8: 421-9.
34. Guridi J, Herrero MT, Luquin MR, Guillén J, Laguna J, Javoy-Agid F, et al. Subthalamotomy in parkinsonian monkeys: behavioral and biochemical analysis. Brain 1996; 119: 1717-28.
35. Hallett M, Litvan I. Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease. Task Force on Surgery for Parkinson's Disease of the American Academy of Neurology Therapeutic and Technology Assessment Committee. Mov Disord 2000; 15: 436-8.
36. Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M. The subthalamic nucleus in the context of movement disorders. Brain 2003; 127: 4-20.
37. Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2004; 24: 7-16.
38. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
39. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 2003; 99: 489-95.
40. Krack P, Batir A, Var Blercom N, Chabardes S, Fraix V, Ardovin C et al. Five-years follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 39: 1925-34.
41. Lang AE, Lozano AM. Parkinson's disease. N Engl J Med 1998; 339: 1130-43.
42. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997; 337: 1036-42.
43. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7: 2-13.
44. Lezak MD. Neuropsychological assessment. HDI Publishers, New York: Oxford, 1995.
45. Lindvall O, McKay R. Brain repair by cell replacement and regeneration. Proc Natl Acad Sci USA 2003; 100: 7430-1.
46. Lopez-Flores G, Morales JM, Tejeiro-Amador, Fernandez-Melor, Alverez-Gouzolet L, Macias-Gouzalet R et al. Anatomic and neurophysiological methods for the targeting and lesioning of the subthalamic nucleus: Cuban experience and review. Neurosurgery 2002; 52: 817-29.
47. Lozano AM. The subthalamic nucleus: myth and opportunities. Mov Disord 2001; 16: 183-4.
48. Macias R, Teijeiro R, Torres A, Alvarez L. Electrophysiological targeting in stereotaxic surgery for Parkinson's disease. Adv Neurol 1997; 74: 175-82.
49. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994; 117: 877-97.
50. Mattis S. Dementia rating scale. In: Bellak L, Karasu TB, editorss. Geriatric psychiatry. A handbook for psychiatrists and primary care physicians. New York: Grune & Stratton; 1976. p. 108-21.
51. McCarter RJ, Walton NH, Rowan AF, Gill SS, Palomo M. Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease. J Neurol Neurosurg Psychiatry 2000; 69: 60-6.
52. McIntosh E, Gray A, Aziz T. Estimating the costs of surgical innovations: the case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease. Mov Disord 2003; 18: 993-9.
53. Merello M, Starkstein S, Nouzeilles MI, Kuzis G, Leiguarda R. Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation. J Neurol Neurosurg Psychiatry 2001; 71: 611-4.
54. Molinuevo JL, Valldeoriola F, Tolosa E, Rumià J, Valls-Solé J, Roldán H, Ferrer E. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000; 57: 983-8.
55. Nandi D, Aziz TZ, Giladi N, Winter J, Stein JF. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain 2002; 125: 2418-30.
56. Obeso JA, Alvarez L, Macias R, Guridi J, Juncos JL, Tejeira J, et al. Lesion of the subthalamic nucleus (STN) in Parkinson's disease (PD). Neurology 1997; 48 (Suppl 3): 138A.
57. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lenciego JL, Artieda J, Gouzalo N et al. Pathophysiology of the basal ganglia in Parkinson's disease. Trends in Neuroscience 2000; 23 (Suppl 10): 8-19.
58. Obeso JA, Olanow CW, Rodriguez-Oroz, Krack P, Kumar R, Lang AE (The Deep-Brain Stimulation for Parkinson's Disease Study Group). Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001a; 345: 956-63.
59. Obeso JA, Rodriguez MC, Guridi J, Álvarez L, Álvarez E, Macias R, et al. Lesion of the basal ganglia and surgery for Parkinson disease. Arch Neurol 2001b; 58: 1165-6.
60. Oh MY, Hodaie M, Kim SH, Alkhani A, Lang AE, Lozano AM. Deep brain stimulator electrodes used for lesioning: proof of principle. Neurosurgery 2001; 49: 363-7.
61. Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM. Long-term hardware related complications of deep brain stimulation. Neurosurgery 2002; 50: 1268-74.
62. Ohye C, Shibasaki T, Hirai T, Wada H, Hirato M, Kawashima Y. Further physiological observations on the ventralis intermedius neurons in the humans. J Neurophysiol 1989; 61: 488-500.
63. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54: 403-14.
64. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000; 123: 1767-83.
65. Parent A, Cosset M, Lebesque M. Anatomical considerations in basal ganglia surgery. Prog Neurol Surg 2000; 15: 21-30.
66. Parkin SG, Gregory RP, Scott R, Bain P, Silburn P, Hall B, et al. Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: a case series of 115 patients. Mov Disord 2002; 17: 682-92.
67. Patel NK, Heywood P, O'Sullivan K, McCarter R, Love S, Gill SS. Unilateral subthalamotomy in the treatment of Parkinson's disease. Brain 2003; 126: 1136-45.
68. Perier C, Tremblay L, Feger J, Hirsch EC. Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat. J Neurosci 2002; 22: 8711-9.
69. Peterson EW, Magoun HW, McCulloch WS and Lindsey DB. Production of postural tremor. J Neurophysiology 1949; 12: 371-84.
70. Postuma RB, Lang AE. Hemiballism: revisiting a classic disorder. Lancet Neurol 2003; 2: 661-8.
71. Rodriguez-Oroz MC, Rodriguez M, Guridi J, Mewes K, Chokkman V, Vitek J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 2001; 124: 1777-90.
72. Rodriguez-Oroz MC, Zamarbide I, Guridi J, Rodriguez Palmero M, Obeso JA. Efficacy of deep-brain stimulation of the subthalamic nucleus in parkinson's disease 4 years after surgery: double-blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004; 75: 1382-5.
73. Saint-Cyr JA, Hoque T, Pereira LC, Dostrovsky JO, Hutchison WD, Mikulis DJ, et al. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg 2002; 97: 152-66.
74. Samuel M, Ceballos-Baumann O, Turjanski N, Gorospe A, Linazasoro G, Holmes AP, et al. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements. An H-2 O PET study. Brain 1997; 120: 1301-14.
75. Scott R, Gregory R, Hines N, Carroll C, Hyman N, Papanasstasiou V, et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain 1998; 121: 659-75.
76. Scott RB, Harrison J, Boulton Ch, Wilson J, Gregory R, Parkin S, et al. Global attentional-executive sequelae following surgical lesions to globus pallidus interna. Brain 2002; 125: 562-74.
77. Su PC, Ma Y, Fukuda M, Mentis MJ, Tseng HM, Yen RF, et al. Metabolic changes following subthalamotomy for advanced Parkinson's disease. Ann Neurol 2001; 50: 514-20.
78. Su PC, Tseng HM, Liu HM, Yen RF, Liou HH. Subthalamotomy for advanced Parkinson disease. J Neurosurg 2002; 97: 598-606.
79. Tasker RR, Siqueira J, Hawrylyshyn P, Organ LW. What happened to VIM-thalamotomy for Parkinson's disease? Appl Neurophysiol 1983; 46: 68-83.
80. Terao T, Takahashi H, Yokochi F, Taniguchi M, Okiyama R, Hamada I. Hemorrhagic complication of stereotactic surgery in patients with movement disorders. J Neurosurg 2003; 98: 1241-6.
81. Terman D, Rubin JE, Yew AC, Wilson CJ. Activity patterns in a model for the subthalamopallidal network of the basal ganglia. J Neurosci 2002; 22: 2963-76.
82. Tseng HM, Su PC, Liu HM. Persistent hemiballism after subthalamotomy: the size of the lesion matters more than the location. Mov Disord 2003; 18: 1209-11.
83. Theodosopoulos PV, Marks WJ Jr, Christine C, Starr PA. Locations of movement-related cells in the human subthalamic nucleus in Parkinson's disease. Mov Disord 2003; 18: 791-8.
84. Trost M, Su PC, Barnes A, Su SL, Yen RF, Tseng HM, et al. Evolving metabolic changes during the first postoperative year after subthalamotomy. J Neurosurg 2003; 99: 872-8.
85. Vilela F, da Silva DJ. Unilateral subhtalamic nucleus lesioning: a safe and effective treatment for Parkinson's disease. Arq Neuropsiquiatr 2002; 60: 935-48.
86. Vitek JL, Bakay RA, Freeman A, Evatt M, Green J, McDonald W, et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann Neurol 2003; 53: 558-69.
87. Whelan BM, Murdoch BE, Theodoras DG, Hall B, Silburn P. Defining a role for the subthalamic nucleus within operative theoretical models of subcortical participation in language. J Neurol Neurosurg Psychiatry 2003; 74: 543-50.
88. Whittier JR, Mettler FA. Studies on the subthalamus of the rhesus monkey. II. Hyperkinesia and other physiological effects of the subthalamic lesions, with special reference to the subthalamic nucleus of Luys. J Comp Neurol 1949; 90: 319-72.
89. Wichmann T, DeLong MR. Functional and pathological models of the basal ganglia. Curr Opin Neurobiol 1996; 6: 751-8.
90. Wichman T, Bergman H, DeLong MR. The primate subthalamic nucleus. III. Changes in motor behaviour and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 1994; 72: 521-9.